[1]
|
俞坤武, 曾秋棠. 《非ST段抬高型急性冠脉综合征诊断和治疗指南(2024)》解读[J]. 临床心血管病杂志, 2024, 40(9): 697-700.
|
[2]
|
张新超, 于学忠, 陈凤英, 等. 急性冠脉综合征急诊快速诊治指南(2019) [J]. 中国急救医学, 2019, 39(4): 301-308.
|
[3]
|
Denktas, A.E. (2021) Ischemia-Guided Approach versus Early Invasive Approach for NSTE-ACS: How Early Is Early? Current Cardiology Reports, 23, Article No. 34. https://doi.org/10.1007/s11886-021-01462-x
|
[4]
|
Bhatt, D.L., Lopes, R.D. and Harrington, R.A. (2022) Diagnosis and Treatment of Acute Coronary Syndromes: A Review. JAMA, 327, 662-675. https://doi.org/10.1001/jama.2022.0358
|
[5]
|
Kotanidis, C.P., Mills, G.B., Bendz, B., Berg, E.S., Hildick-Smith, D., Hirlekar, G., et al. (2024) Invasive vs. Conservative Management of Older Patients with Non-ST-Elevation Acute Coronary Syndrome: Individual Patient Data Meta-analysis. European Heart Journal, 45, 2052-2062. https://doi.org/10.1093/eurheartj/ehae151
|
[6]
|
Amsterdam, E.A. and Wenger, N.K. (2015) The 2014 American College of Cardiology ACC/American Heart Association Guideline for the Management of Patients with Non-ST‐Elevation Acute Coronary Syndromes: Ten Contemporary Recommendations to Aid Clinicians in Optimizing Patient Outcomes. Clinical Cardiology, 38, 121-123. https://doi.org/10.1002/clc.22354
|
[7]
|
张维, 辉红蕾, 李金龙, 许钟艺, 尹冶, 王玉明. 不同性别和年龄的非心肌损伤人群血清高敏心肌肌钙蛋白T水平差异[J]. 中国循环杂志, 2020, 35(1): 31-36.
|
[8]
|
Granger, C.B., Goldberg, R.J., Dabbous, O., Pieper, K.S., Eagle, K.A., Cannon, C.P., et al. (2003) Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events. Archives of Internal Medicine, 163, 2345-2353. https://doi.org/10.1001/archinte.163.19.2345
|
[9]
|
黄振华, 廖瑾莉, 肖孝勇, 叶子, 蒋鹏, 陈伟栋, 等. GRACE评分对急性胸痛患者30 d心血管不良事件的预测价值[J]. 中山大学学报(医学科学版), 2018, 39(1): 82-86.
|
[10]
|
张玲玲. 急诊科首次肌钙蛋白I联合GRACE评分对急性心肌梗死的预测价值分析[J]. 中国现代药物应用, 2025, 19(4): 74-77.
|
[11]
|
Farooq, V., Head, S.J., Kappetein, A.P. and Serruys, P.W. (2013) Widening Clinical Applications of the SYNTAX Score. Heart, 100, 276-287. https://doi.org/10.1136/heartjnl-2013-304273
|
[12]
|
Serruys, P.W., Morice, M., Kappetein, A.P., Colombo, A., Holmes, D.R., Mack, M.J., et al. (2009) Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. New England Journal of Medicine, 360, 961-972. https://doi.org/10.1056/nejmoa0804626
|
[13]
|
Virmani, R., Kolodgie, F.D., Burke, A.P., Farb, A. and Schwartz, S.M. (2000) Lessons from Sudden Coronary Death: A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 1262-1275. https://doi.org/10.1161/01.atv.20.5.1262
|
[14]
|
Libby, P. (2002) Inflammation in Atherosclerosis. Nature, 420, 868-874. https://doi.org/10.1038/nature01323
|
[15]
|
Savarese, G., Edner, M., Dahlström, U., Perrone-Filardi, P., Hage, C., Cosentino, F., et al. (2015) Comparative Associations between Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers and Their Combination, and Outcomes in Patients with Heart Failure and Reduced Ejection Fraction. International Journal of Cardiology, 199, 415-423. https://doi.org/10.1016/j.ijcard.2015.07.051
|
[16]
|
Jugdutt, B.I. and Amy, R.W.M. (1986) Healing after Myocardial Infarction in the Dog: Changes in Infarct Hydroxyproline and Topography. Journal of the American College of Cardiology, 7, 91-102. https://doi.org/10.1016/s0735-1097(86)80265-0
|
[17]
|
Fishbein, M.C., Meerbaum, S., Rit, J., Lando, U., Kanmatsuse, K., Mercier, J.C., et al. (1981) Early Phase Acute Myocardial Infarct Size Quantification: Validation of the Triphenyl Tetrazolium Chloride Tissue Enzyme Staining Technique. American Heart Journal, 101, 593-600. https://doi.org/10.1016/0002-8703(81)90226-x
|
[18]
|
Sun, Y. and Weber, K.T. (2000) Infarct Scar: A Dynamic Tissue. Cardiovascular Research, 46, 250-256. https://doi.org/10.1016/s0008-6363(00)00032-8
|
[19]
|
谢亚芹, 刘宏伟, 李秀芬, 等. 转化生长因子-β和结缔组织生长因子在慢性心力衰竭大鼠心肌纤维化中的动态表达[J]. 解剖学杂志, 2011, 34(4): 446-449.
|
[20]
|
Jahan, N. and Hannila, S.S. (2015) Transforming Growth Factor β-Induced Expression of Chondroitin Sulfate Proteoglycans Is Mediated through Non-Smad Signaling Pathways. Experimental Neurology, 263, 372-384. https://doi.org/10.1016/j.expneurol.2014.10.023
|
[21]
|
Almendral, J.M., Sommer, D., Macdonald-Bravo, H., Burckhardt, J., Perera, J. and Bravo, R. (1988) Complexity of the Early Genetic Response to Growth Factors in Mouse Fibroblasts. Molecular and Cellular Biology, 8, 2140-2148. https://doi.org/10.1128/mcb.8.5.2140
|
[22]
|
Bradham, D.M., Igarashi, A., Potter, R.L. and Grotendorst, G.R. (1991) Connective Tissue Growth Factor: A Cysteine-Rich Mitogen Secreted by Human Vascular Endothelial Cells Is Related to the SRC-Induced Immediate Early Gene Product CEF-10. The Journal of Cell Biology, 114, 1285-1294. https://doi.org/10.1083/jcb.114.6.1285
|
[23]
|
Leask, A., Parapuram, S.K., Shi‐wen, X. and Abraham, D.J. (2009) Connective Tissue Growth Factor (CTGF, CCN2) Gene Regulation: A Potent Clinical Bio‐Marker of Fibroproliferative Disease? Journal of Cell Communication and Signaling, 3, 89-94. https://doi.org/10.1007/s12079-009-0037-7
|
[24]
|
Lipson, K.E., Wong, C., Teng, Y. and Spong, S. (2012) CTGF Is a Central Mediator of Tissue Remodeling and Fibrosis and Its Inhibition Can Reverse the Process of Fibrosis. Fibrogenesis & Tissue Repair, 5, S24. https://doi.org/10.1186/1755-1536-5-s1-s24
|
[25]
|
Pan, L., Yamauchi, K., Uzuki, M., Nakanishi, T., Takigawa, M., Inoue, H., et al. (2001) Type II Alveolar Epithelial Cells and Interstitial Fibroblasts Express Connective Tissue Growth Factor in IPF. European Respiratory Journal, 17, 1220-1227. https://doi.org/10.1183/09031936.01.00074101
|
[26]
|
Yokoi, H., Mukoyama, M., Sugawara, A., Mori, K., Nagae, T., Makino, H., et al. (2002) Role of Connective Tissue Growth Factor in Fibronectin Expression and Tubulointerstitial Fibrosis. American Journal of Physiology-Renal Physiology, 282, F933-F942. https://doi.org/10.1152/ajprenal.00122.2001
|
[27]
|
Hayashi, N., Kakimuma, T., Soma, Y., et al. (2002) Connective Tissue Growth Factor Is Directly Related to Liver Fibrosis. Hepatogas-Troenterology, 49, 133-135.
|
[28]
|
Dean, R.G., Balding, L.C., Candido, R., Burns, W.C., Cao, Z., Twigg, S.M., et al. (2005) Connective Tissue Growth Factor and Cardiac Fibrosis after Myocardial Infarction. Journal of Histochemistry & Cytochemistry, 53, 1245-1256. https://doi.org/10.1369/jhc.4a6560.2005
|
[29]
|
Oemar, B.S. and Lüscher, T.F. (1997) Connective Tissue Growth Factor. Friend or Foe? Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 1483-1489. https://doi.org/10.1161/01.atv.17.8.1483
|
[30]
|
Ross, R. (1999) Mechanisms of Disease: Atherosclerosis—An Inflammatory Disease. The New England Journal of Medicine, 41, 376.
|
[31]
|
Ohnishi, H., Oka, T., Kusachi, S., Nakanishi, T., Takeda, K., Nakahama, M., et al. (1998) Increased Expression of Connective Tissue Growth Factor in the Infarct Zone of Experimentally Induced Myocardial Infarction in Rats. Journal of Molecular and Cellular Cardiology, 30, 2411-2422. https://doi.org/10.1006/jmcc.1998.0799
|
[32]
|
Grotendorst, G.R. and Duncan, M.R. (2005) Individual Domains of Connective Tissue Growth Factor Regulate Fibroblast Proliferation and Myofibroblast Differentiation. The FASEB Journal, 19, 729-738. https://doi.org/10.1096/fj.04-3217com
|
[33]
|
Watts, K.L. and Spiteri, M.A. (2004) Connective Tissue Growth Factor Expression and Induction by Transforming Growth Factor-β Is Abrogated by Simvastatin via a Rho Signaling Mechanism. American Journal of Physiology-Lung Cellular and Molecular Physiology, 287, L1323-L1332. https://doi.org/10.1152/ajplung.00447.2003
|
[34]
|
敖翔. CTGF在心血管疾病中的研究进展[J]. 国外医学(生理、病理科学与临床分册), 2003(5): 466-468.
|
[35]
|
李勇, 李莉, 祁春梅, 等. 急性ST段抬高型心肌梗死患者血清结缔组织生长因子表达的研究[J]. 中国循环杂志, 2015, 30(6): 540-542.
|
[36]
|
张春阳. 结缔组织生长因子在冠状动脉狭窄形成中的作用及临床诊断价值研究[D]: [硕士学位论文]. 贵阳: 贵州医科大学, 2016.
|